
|Articles|April 21, 2008
Treximet, a sumatriptan and naproxen combination treatment, approved for migraine
GlaxoSmithKline gets FDA nod for combination migraine treatment
Advertisement
Acute migrane sufferers will now have a new option for treatment with a
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Wicked Good Cardiometabolic Chat: Identifying and Managing MASH
2
Optimizing MTM Services for Patients With Cardiometabolic Conditions: A Practical Guide for Pharmacists
3
Study Links Antipsychotic Use to Rapid Rise in Youth Type 2 Diabetes
4
Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits
5






















